Evidence map›Paper›PMID 27624779›Full record

ArticleMucosal immunology2017

Bacterial virulence factor inhibits caspase-4/11 activation in intestinal epithelial cells.

M A Pallett, V F Crepin, N Serafini, M Habibzay, O Kotik, J Sanchez-Garrido, J P Di Santo, A R Shenoy, C N Berger, G Frankel

Open access · bronzeAbstract read
In one paragraph

Article in Mucosal immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. mBio · 2023
    Article
  10. bioRxiv : the preprint server for biology · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

M A PallettDepartment of Life Sciences, MRC Centre for Molecular Bacteriology and Infection, Imperial College, London, UK.
V F CrepinDepartment of Life Sciences, MRC Centre for Molecular Bacteriology and Infection, Imperial College, London, UK.
N SerafiniInnate Immunity Unit, Institut Pasteur, Paris, France.
M HabibzayDepartment of Life Sciences, MRC Centre for Molecular Bacteriology and Infection, Imperial College, London, UK.
O KotikDepartment of Life Sciences, MRC Centre for Molecular Bacteriology and Infection, Imperial College, London, UK.
J Sanchez-GarridoDepartment of Medicine, MRC Centre for Molecular Bacteriology and Infection, Imperial College, London, UK.
J P Di SantoInnate Immunity Unit, Institut Pasteur, Paris, France.
A R ShenoyDepartment of Medicine, MRC Centre for Molecular Bacteriology and Infection, Imperial College, London, UK.
C N BergerDepartment of Life Sciences, MRC Centre for Molecular Bacteriology and Infection, Imperial College, London, UK.
G FrankelDepartment of Life Sciences, MRC Centre for Molecular Bacteriology and Infection, Imperial College, London, UK.
Imperial College London · GBInserm · FR

Funding

Biotechnology and Biological Sciences Research CouncilMedical Research Council MR/K019007/1Wellcome Trust 107057Wellcome Trust 108246/Z/15/Z
6 · The paper itself

Abstract

The human pathogen enteropathogenic Escherichia coli (EPEC), as well as the mouse pathogen Citrobacter rodentium, colonize the gut mucosa via attaching and effacing lesion formation and cause diarrheal diseases. EPEC and C. rodentium type III secretion system (T3SS) effectors repress innate immune responses and infiltration of immune cells. Inflammatory caspases such as caspase-1 and caspase-4/11 are crucial mediators of host defense and inflammation in the gut via their ability to process cytokines such as interleukin (IL)-1β and IL-18. Here we report that the effector NleF binds the catalytic domain of caspase-4 and inhibits its proteolytic activity. Following infection of intestinal epithelial cells (IECs) EPEC inhibited caspase-4 and IL-18 processing in an NleF-dependent manner. Depletion of caspase-4 in IECs prevented the secretion of mature IL-18 in response to infection with EPECΔnleF. NleF-dependent inhibition of caspase-11 in colons of mice prevented IL-18 secretion and neutrophil influx at early stages of C. rodentium infection. Neither wild-type C. rodentium nor C. rodentiumΔnleF triggered neutrophil infiltration or IL-18 secretion in Cas11 or Casp1/11-deficient mice. Thus, IECs have a key role in modulating early innate immune responses in the gut via a caspase-4/11-IL-18 axis, which is targeted by virulence factors encoded by enteric pathogens.

Indexed as

Immune EvasionAnimalsCaspasesCaspases, InitiatorCells, CulturedCitrobacter rodentiumEnterobacteriaceae InfectionsEnteropathogenic Escherichia coliEscherichia coli InfectionsEscherichia coli ProteinsFemaleHumansImmunity, InnateInterleukin-18Intestinal MucosaMiceCASP4 protein, humanCasp4 protein, mouseCaspasesCaspases, InitiatorEscherichia coli ProteinsInterleukin-18NleF protein, E coliRNA, Small InterferingVirulence Factors

Identifiers

PMID27624779
PMCPMC5159625
OpenAlexW2518931467

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.